Aptevo Therapeutics Debt to Equity Ratio 2014-2020 | APVO

Current and historical debt to equity ratio values for Aptevo Therapeutics (APVO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aptevo Therapeutics debt/equity for the three months ending June 30, 2020 was 0.00.
Aptevo Therapeutics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.02B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.02B 0.00
2019-06-30 $0.02B $0.03B 0.75
2019-03-31 $0.02B $0.04B 0.50
2018-12-31 $0.02B $0.03B 0.63
2018-09-30 $0.02B $0.04B 0.44
2018-06-30 $0.02B $0.06B 0.28
2018-03-31 $0.01B $0.07B 0.20
2017-12-31 $0.02B $0.08B 0.19
2017-09-30 $0.02B $0.09B 0.19
2017-06-30 $0.02B $0.05B 0.37
2017-03-31 $0.02B $0.06B 0.30
2016-12-31 $0.02B $0.05B 0.36
2016-09-30 $0.02B $0.06B 0.28
2016-06-30 $0.00B $0.10B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.10B 0.00
2013-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.023B $0.032B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.754B 15.29
Bristol Myers Squibb (BMY) United States $131.802B 10.15
CSL (CSLLY) Australia $95.523B 0.00
Gilead Sciences (GILD) United States $78.044B 11.24
Vertex Pharmaceuticals (VRTX) United States $68.537B 38.25
Regeneron Pharmaceuticals (REGN) United States $59.310B 22.68
Biogen (BIIB) United States $42.751B 7.32
Illumina (ILMN) United States $41.801B 48.61
Seattle Genetics (SGEN) United States $31.220B 0.00
Moderna (MRNA) United States $25.715B 0.00
BeiGene (BGNE) Cayman Islands $25.002B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.552B 10.23
Genmab (GMAB) Denmark $22.887B 14.46
Genmab (GNMSF) Denmark $21.934B 5.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.715B 0.00
Immunomedics (IMMU) United States $19.717B 0.00
Incyte (INCY) United States $18.605B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.553B 36.39
Alnylam Pharmaceuticals (ALNY) United States $15.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.216B 0.00
Exact Sciences (EXAS) United States $14.162B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.888B 100.76
QIAGEN (QGEN) Netherlands $11.654B 29.58
ARGENX SE-ADR (ARGX) Netherlands $11.426B 0.00
Sarepta Therapeutics (SRPT) United States $10.815B 0.00
Guardant Health (GH) United States $10.579B 0.00
Bio-Techne Corp (TECH) United States $8.954B 61.43
Galapagos (GLPG) Belgium $8.644B 31.32
Ascendis Pharma (ASND) Denmark $7.886B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.643B 19.01
Repligen (RGEN) United States $7.347B 116.62
Exelixis (EXEL) United States $7.181B 26.11
Mirati Therapeutics (MRTX) United States $7.172B 0.00
MyoKardia (MYOK) United States $6.891B 0.00
Acceleron Pharma (XLRN) United States $6.291B 0.00
Novavax (NVAX) United States $6.277B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.236B 0.00
Adaptive Biotechnologies (ADPT) United States $6.222B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.088B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.846B 181.11
Emergent Biosolutions (EBS) United States $5.245B 20.78
Blueprint Medicines (BPMC) United States $4.877B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.848B 0.00
Zai Lab (ZLAB) China $4.481B 0.00
China Biologic Products (CBPO) China $4.353B 25.84
Arena Pharmaceuticals (ARNA) United States $4.211B 0.00
Vir Biotechnology (VIR) United States $4.101B 0.00
MorphoSys AG (MOR) Germany $4.040B 52.95
NeoGenomics (NEO) United States $3.871B 1168.33
Legend Biotech (LEGN) United States $3.739B 0.00
Denali Therapeutics (DNLI) United States $3.687B 0.00
Bluebird Bio (BLUE) United States $3.687B 0.00
Amicus Therapeutics (FOLD) United States $3.571B 0.00
Halozyme Therapeutics (HALO) United States $3.527B 0.00
Reata Pharmaceuticals (RETA) United States $3.453B 0.00
Insmed (INSM) United States $3.396B 0.00
Principia Biopharma (PRNB) United States $3.319B 0.00
Global Blood Therapeutics (GBT) United States $3.274B 0.00
Fate Therapeutics (FATE) United States $3.126B 0.00
Twist Bioscience (TWST) United States $2.970B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.708B 0.00
Alkermes (ALKS) Ireland $2.629B 55.10
Inovio Pharmaceuticals (INO) United States $2.575B 0.00
I-Mab (IMAB) China $2.235B 0.00
Sorrento Therapeutics (SRNE) United States $2.224B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Mesoblast (MESO) Australia $2.016B 0.00
Zymeworks (ZYME) Canada $2.006B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Seres Therapeutics (MCRB) United States $1.926B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.811B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.798B 0.00
Intra-Cellular Therapies (ITCI) United States $1.764B 0.00
Revance Therapeutics (RVNC) United States $1.696B 0.00
Eidos Therapeutics (EIDX) United States $1.693B 0.00
UniQure (QURE) Netherlands $1.652B 0.00
Cytokineticsorporated (CYTK) United States $1.548B 0.00
Ligand Pharmaceuticals (LGND) United States $1.516B 51.26
Zealand Pharma (ZEAL) Denmark $1.420B 0.00
Amarin (AMRN) Ireland $1.403B 0.00
Viela Bio (VIE) United States $1.394B 0.00
Sangamo Therapeutics (SGMO) United States $1.383B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Beam Therapeutics (BEAM) United States $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.311B 0.00
Coherus BioSciences (CHRS) United States $1.286B 7.50
Mersana Therapeutics (MRSN) United States $1.260B 0.00
Intellia Therapeutics (NTLA) United States $1.223B 0.00
Epizyme (EPZM) United States $1.190B 0.00
Arcus Biosciences (RCUS) United States $1.146B 0.00
NGM Biopharmaceuticals (NGM) United States $1.079B 0.00
Compugen (CGEN) Israel $1.061B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.036B 0.00
REGENXBIO (RGNX) United States $1.008B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.008B 0.00
Castle Biosciences (CSTL) United States $0.979B 0.00
Athenex (ATNX) United States $0.965B 0.00
Arvinas (ARVN) United States $0.937B 0.00
Retrophin (RTRX) United States $0.918B 0.00
Heska (HSKA) United States $0.918B 0.00
Alcobra (ARCT) United States $0.914B 0.00
Myriad Genetics (MYGN) United States $0.904B 0.00
Alector (ALEC) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.847B 0.00
Vericel (VCEL) United States $0.814B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.811B 0.00
Genetron Holdings (GTH) China $0.804B 0.00
Pliant Therapeutics (PLRX) United States $0.795B 0.00
Morphic Holding (MORF) United States $0.768B 0.00
NantKwest (NK) United States $0.740B 0.00
Cellectis S.A (CLLS) France $0.737B 0.00
Agenus (AGEN) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.720B 0.00
Protagonist Therapeutics (PTGX) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.700B 0.00
Codexis (CDXS) United States $0.691B 0.00
VBI Vaccines (VBIV) United States $0.673B 0.00
Kadmon Holdings (KDMN) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cara Therapeutics (CARA) United States $0.625B 0.00
Intrexon (PGEN) United States $0.603B 0.00
Northwest Biotherapeutics (NWBO) United States $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.560B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.528B 0.00
Geron (GERN) United States $0.522B 0.00
Scholar Rock Holding (SRRK) United States $0.517B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.512B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.512B 4.48
Forte Biosciences (FBRX) United States $0.511B 0.00
Clovis Oncology (CLVS) United States $0.502B 0.00
Albireo Pharma (ALBO) United States $0.488B 0.00
Cel-Sci (CVM) United States $0.482B 0.00
Dynavax Technologies (DVAX) United States $0.473B 0.00
Celldex Therapeutics (CLDX) United States $0.473B 0.00
Anika Therapeutics (ANIK) United States $0.472B 20.65
Aquinox Pharmaceuticals (NLTX) United States $0.469B 0.00
MeiraGTx Holdings (MGTX) United States $0.451B 0.00
Cue Biopharma (CUE) United States $0.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.445B 0.00
IVERIC Bio (ISEE) United States $0.440B 0.00
Pfenex (PFNX) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Kala Pharmaceuticals (KALA) United States $0.422B 0.00
MannKind (MNKD) United States $0.419B 0.00
Syros Pharmaceuticals (SYRS) United States $0.410B 0.00
UROGEN PHARMA (URGN) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.400B 0.00
Amryt Pharma (AMYT) United Kingdom $0.397B 0.00
Avid Bioservices (CDMO) United States $0.396B 0.00
Athersys (ATHX) United States $0.395B 0.00
AnaptysBio (ANAB) United States $0.390B 0.00
BioDelivery Sciences (BDSI) United States $0.388B 27.43
Puma Biotechnology (PBYI) United States $0.382B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.380B 0.00
Sutro Biopharma (STRO) United States $0.370B 0.00
Kamada (KMDA) Israel $0.367B 17.53
PDL BioPharma (PDLI) United States $0.361B 0.00
Trevena (TRVN) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.348B 0.00
Fortress Biotech (FBIO) United States $0.340B 0.00
Merus (MRUS) Netherlands $0.340B 0.00
IBio (IBIO) United States $0.337B 0.00
ANI Pharmaceuticals (ANIP) United States $0.331B 7.81
Bicycle Therapeutics (BCYC) United Kingdom $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.312B 0.00
Precision BioSciences (DTIL) United States $0.309B 0.00
CytomX Therapeutics (CTMX) United States $0.303B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
Innate Pharma S.A (IPHA) France $0.289B 0.00
Prometic Life Sciences (LMNL) Canada $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.255B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.253B 0.00
Selecta Biosciences (SELB) United States $0.253B 0.00
Cardiff Oncology (CRDF) United States $0.249B 0.00
Affimed (AFMD) Germany $0.249B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Arbutus Biopharma (ABUS) United States $0.242B 0.00
Cyclerion Therapeutics (CYCN) United States $0.235B 0.00
Pluristem Therapeutics (PSTI) Israel $0.227B 0.00
NextCure (NXTC) United States $0.226B 0.00
TELA Bio (TELA) United States $0.220B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
XOMA (XOMA) United States $0.206B 0.00
Verastem (VSTM) United States $0.205B 0.00
Dyadic (DYAI) United States $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Aduro Biotech (ADRO) United States $0.185B 0.00
Liquidia Technologies (LQDA) United States $0.183B 0.00
Kindred Biosciences (KIN) United States $0.182B 0.00
Biofrontera AG (BFRA) Germany $0.177B 0.00
ADMA Biologics Inc (ADMA) United States $0.176B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
DBV Technologies S.A (DBVT) France $0.174B 0.00
Eton Pharmaceuticals (ETON) United States $0.171B 0.00
Cerecor (CERC) United States $0.169B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.167B 0.00
Abeona Therapeutics (ABEO) United States $0.165B 0.00
Checkpoint Therapeutics (CKPT) United States $0.165B 0.00
CorMedix Inc (CRMD) United States $0.163B 0.00
Exicure (XCUR) United States $0.157B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.155B 7.25
Five Prime Therapeutics (FPRX) United States $0.154B 0.00
VolitionRX (VNRX) United States $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Aptinyx (APTX) United States $0.146B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Aytu Bioscience (AYTU) United States $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.140B 0.00
GENFIT S.A (GNFT) France $0.139B 0.00
AquaBounty Technologies (AQB) United States $0.137B 0.00
Bellus Health (BLU) Canada $0.130B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Cidara Therapeutics (CDTX) United States $0.123B 0.00
Applied Genetic Technologies (AGTC) United States $0.122B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.108B 2.77
Pieris Pharmaceuticals (PIRS) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.106B 5.37
Gritstone Oncology (GRTS) United States $0.103B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.098B 0.00
Unum Therapeutics (UMRX) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.094B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Oncobiologics (OTLK) United States $0.084B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Evogene (EVGN) Israel $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.060B 0.00
AmpliPhi Biosciences (ARMP) United States $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
Curis (CRIS) United States $0.056B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Emmaus Life Sciences (EMMA) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
AnPac Bio-Medical Science (ANPC) China $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Novogen (KZIA) Australia $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
Signal Genetics (MGEN) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
BioCardia (BCDA) United States $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Celsion (CLSN) United States $0.024B 0.00
Acorda Therapeutics (ACOR) United States $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00